TomoTherapy increases revenue, decreases net income for Q3
For the third quarter of 2007 (end-Sept.30), TomoTherapy reported the unaudited revenue results of $59.2 million, a 59 percent increase from $37.2 million for the third quarter of 2006.

The Madison, Wis.-based TomoTherapy said that it had a decrease in net income, which was $2.5 million in the third quarter of 2007, compared to net income of $3.14 million for the same period last year.

Fred Robertson, CEO of TomoTherapy, attributes the revenue gain to the sales of the Hi-Art treatment system, a radiation therapy system.